Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology
Clinical trial NCT01020838 · COMPLETED
Trial details
- NCT number
- NCT01020838
- Sponsor
- Lantheus Biosciences Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-09-01
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.